Emmaus Medical, Inc.
4 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Pharmacokinetics and Safety of Endari (L-glutamine) in Sickle Cell Disease Patients (NCT04684381) | Emmaus Medical, Inc. | 2021-01-04 |
| L-glutamine Treatment in Patients With Diverticulosis (NCT05106101) | Emmaus Medical, Inc. | 2019-07-19 |
| A Phase III Safety and Efficacy Study of L-Glutamine to Treat Sickle Cell Disease or Sickle βo-thalassemia (NCT01179217) | Emmaus Medical, Inc. | 2010-05-01 |
| L-Glutamine Therapy for Sickle Cell Anemia and Sickle ß0 Thalassemia (NCT00125788) | Emmaus Medical, Inc. | 2004-03-01 |
Track Emmaus Medical, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.